Sequentially Self-Assembled Supramolecular Nanocomplexes Enable Systemic Cas9 RNP Delivery and In Vivo Tumor Genome Editing
ACS Applied Materials & Interfaces · 2026
DOI: 10.1021/acsami.6c14858 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Takumi Matsuo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Chemistry and Life Science, Institute of Integrated Research, Institute of Science Tokyo, 4259 Nagatsuta-cho, Midori-ku, Yokohama, Kan…. Hauptthemen laut MEDLINE: Gene Editing, Ribonucleoproteins, CRISPR-Associated Protein 9, Neoplasms. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
In vivo genome editing utilizing Cas9/sgRNA ribonucleoproteins (RNPs) holds substantial therapeutic promise, yet rapid bloodstream clearance and degradation of RNPs have hindered its accumulation within the target site and effective gene editing. Herein, we report a supramolecular ternary complex platform where RNPs are co-assembled with tannic acid (TA) and phenylboronic acid (PBA)-conjugated polymers through sequential self-assembly. This ∼30 nm core–shell structure protects RNPs from enzymatic degradation and dissociates selectively at endosomal pH. Upon intravenous administration in subcutaneous tumor-bearing mice, the ternary complex exhibits prolonged blood circulation and preferential tumor accumulation, achieving 37.2% gene editing at tumor sites compared with only 1.5% for free RNPs. The platform successfully disrupts PLK1 in subcutaneous tumors, accompanied by significant tumor growth suppression. This is further applied to a KRASG13D-mutant tumor model, in which treatment delayed tumor growth. By integrating sequential supramolecular self-assembly with stimuli-responsive cargo release, this strategy presents a promising approach for systemic RNP delivery and tumor genome editing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Chemistry and Life Science, Institute of Integrated Research, Institute of Science Tokyo, 4259 Nagatsuta-cho, Midori-ku, Yokohama, Kanagawa226-8503, Japan.
- Department of Life Science and Technology, School of Life Science and Technology, Institute of Science Tokyo, 4259 Nagatsuta-cho, Midori-ku, Yokohama, Kanagawa226-8503, Japan.
- Innovation Center of Nanomedicine (iCONM), Kawasaki Institute of Industrial Promotion, 3-25-14 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa210-0821, Japan.
- Department of Life Sciences, Graduate School of Arts and Sciences, the University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo153-8902, Japan.
ORCID-Profile: Takumi Matsuo, Yuto Honda, Takahiro Nomoto, Yutaka Miura, Nobuhiro Nishiyama
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Science and Technology Agency
Zitieren
APA
Matsuo, T., Honda, Y., Chino, T., Nomoto, T., Osakabe, Y., Miura, Y., & Nishiyama, N. (2026). Sequentially Self-Assembled Supramolecular Nanocomplexes Enable Systemic Cas9 RNP Delivery and In Vivo Tumor Genome Editing. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c14858
Vancouver
Matsuo T, Honda Y, Chino T, Nomoto T, Osakabe Y, Miura Y, et al. Sequentially Self-Assembled Supramolecular Nanocomplexes Enable Systemic Cas9 RNP Delivery and In Vivo Tumor Genome Editing. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c14858
BibTeX
@article{Matsuo2026,
author = {Matsuo, Takumi and Honda, Yuto and Chino, Toshizumi and Nomoto, Takahiro and Osakabe, Yuriko and Miura, Yutaka and Nishiyama, Nobuhiro},
title = {Sequentially Self-Assembled Supramolecular Nanocomplexes Enable Systemic Cas9 RNP Delivery and In Vivo Tumor Genome Editing},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c14858}
}
EUVIMED